Bristol Myers Squibb (CELG-RI) Current Deferred Tax Assets (2009 - 2015)

Bristol Myers Squibb (CELG-RI) has reported Current Deferred Tax Assets for 7 consecutive years, with $1.7 billion the latest figure, recorded in Q3 2015.

• In Q3 2015, Current Deferred Tax Assets rose 14.64% year-over-year to $1.7 billion; the TTM figure through Sep 2015 stood at $1.7 billion (up 14.64% YoY), while the FY2014 annual figure was $1.6 billion, down 3.35% from the prior year.
• Current Deferred Tax Assets eased to $1.7 billion in Q3 2015 per CELG-RI's latest filing, from $1.9 billion in the prior quarter.
• Across five years, Current Deferred Tax Assets topped out at $2.0 billion in Q3 2013 and bottomed at $1.1 billion in Q2 2011.
• Historically, Current Deferred Tax Assets has averaged $1.5 billion across 5 years, with a median of $1.5 billion in 2014.
• Annual changes were most pronounced in 2013 — Current Deferred Tax Assets jumped 66.81% — and 2014, when it slumped 30.82%.
• Bristol Myers Squibb's Current Deferred Tax Assets stood at $1.2 billion in 2011, then soared by 33.08% to $1.6 billion in 2012, then gained by 6.51% to $1.7 billion in 2013, then slipped by 3.35% to $1.6 billion in 2014, then gained by 5.29% to $1.7 billion in 2015.
• Business Quant data shows CELG-RI's Current Deferred Tax Assets at $1.7 billion in Q3 2015, $1.9 billion in Q2 2015, and $1.9 billion in Q1 2015.